Nalysnyk L[au] - Search Results

Year	Number of Results
2001	1
2003	2
2004	1
2007	1
2008	1
2009	1
2010	1
2011	1
2012	1
2013	1
2014	2
2016	1
2017	2
2018	2
2020	1
2021	1
2023	0

1

Budget Impact Analysis of Eliglustat for the Treatment of Gaucher Disease Type 1 in the United States.

Nalysnyk L, Sugarman R, Cele C, Uyei J, Ward A. Nalysnyk L, et al. J Manag Care Spec Pharm. 2018 Oct;24(10):1002-1008. doi: 10.18553/jmcp.2018.24.10.1002. J Manag Care Spec Pharm. 2018. PMID: 30247105

2

Clinical relevance of endpoints in clinical trials for acid sphingomyelinase deficiency enzyme replacement therapy.

Jones SA, McGovern M, Lidove O, Giugliani R, Mistry PK, Dionisi-Vici C, Munoz-Rojas MV, Nalysnyk L, Schecter AD, Wasserstein M. Jones SA, et al. Among authors: nalysnyk l. Mol Genet Metab. 2020 Sep-Oct;131(1-2):116-123. doi: 10.1016/j.ymgme.2020.06.008. Epub 2020 Jun 24. Mol Genet Metab. 2020. PMID: 32616389 Free article. Review.

3

OnabotulinumtoxinA muscle injection patterns in adult spasticity: a systematic literature review.

Nalysnyk L, Papapetropoulos S, Rotella P, Simeone JC, Alter KE, Esquenazi A. Nalysnyk L, et al. BMC Neurol. 2013 Sep 8;13:118. doi: 10.1186/1471-2377-13-118. BMC Neurol. 2013. PMID: 24011236 Free PMC article. Review.

4

Gaucher disease epidemiology and natural history: a comprehensive review of the literature.

Nalysnyk L, Rotella P, Simeone JC, Hamed A, Weinreb N. Nalysnyk L, et al. Hematology. 2017 Mar;22(2):65-73. doi: 10.1080/10245332.2016.1240391. Epub 2016 Oct 20. Hematology. 2017. PMID: 27762169 Review.

5

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.

Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Nalysnyk L, et al. Eur Respir Rev. 2012 Dec 1;21(126):355-61. doi: 10.1183/09059180.00002512. Eur Respir Rev. 2012. PMID: 23204124 Free PMC article. Review.

6

Ultrasonic and nonultrasonic instrumentation: a systematic review and meta-analysis.

Matthews B, Nalysnyk L, Estok R, Fahrbach K, Banel D, Linz H, Landman J. Matthews B, et al. Among authors: nalysnyk l. Arch Surg. 2008 Jun;143(6):592-600. doi: 10.1001/archsurg.143.6.592. Arch Surg. 2008. PMID: 18559754 Review.

7

Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature.

Kistler KD, Nalysnyk L, Rotella P, Esser D. Kistler KD, et al. Among authors: nalysnyk l. BMC Pulm Med. 2014 Aug 16;14:139. doi: 10.1186/1471-2466-14-139. BMC Pulm Med. 2014. PMID: 25127540 Free PMC article. Review.

8

A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher disease.

Hadi M, Swinburn P, Nalysnyk L, Hamed A, Mehta A. Hadi M, et al. Among authors: nalysnyk l. Orphanet J Rare Dis. 2018 Sep 10;13(1):159. doi: 10.1186/s13023-018-0903-6. Orphanet J Rare Dis. 2018. PMID: 30201003 Free PMC article. Review.

9

Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis.

Nalysnyk L, Fahrbach K, Reynolds MW, Zhao SZ, Ross S. Nalysnyk L, et al. Heart. 2003 Jul;89(7):767-72. doi: 10.1136/heart.89.7.767. Heart. 2003. PMID: 12807853 Free PMC article. Review.

10

Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature.

Nalysnyk L, Hernandez-Medina M, Krishnarajah G. Nalysnyk L, et al. Diabetes Obes Metab. 2010 Apr;12(4):288-98. doi: 10.1111/j.1463-1326.2009.01160.x. Diabetes Obes Metab. 2010. PMID: 20380649 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results